Search Results - "Ho, R. L. K."

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    HBx mutants differentially affect the activation of hypoxia-inducible factor-1α in hepatocellular carcinoma by Liu, L-p, Hu, B-g, Ye, C, Ho, R L K, Chen, G G, Lai, P B S

    Published in British journal of cancer (18-02-2014)
    “…Background: Mutations in HBx gene are frequently found in HBV-associated hepatocellular carcinoma (HCC). Activation of hypoxia-inducible factor-1 α (HIF-1 α )…”
    Get full text
    Journal Article
  2. 2

    Anti-angiogenic pathway associations of the 3p21.3 mapped BLU gene in nasopharyngeal carcinoma by Cheng, Y, Ho, R L K Y, Chan, K C, Kan, R, Tung, E, Lung, H L, Yau, W L, Cheung, A K L, Ko, J M Y, Zhang, Z F, Luo, D Z, Feng, Z B, Chen, S, Guan, X Y, Kwong, D, Stanbridge, E J, Lung, M L

    Published in Oncogene (06-08-2015)
    “…Zinc-finger, MYND-type containing 10 ( ZMYND10 ), or more commonly called BLU, expression is frequently downregulated in nasopharyngeal carcinoma (NPC) and…”
    Get full text
    Journal Article
  3. 3

    Single nucleotide polymorphism in the promoter region of human alpha-fetoprotein (AFP) gene and its significance in hepatocellular carcinoma (HCC) by Chen, G.G, Ho, R.L.K, Wong, J, Lee, K.F, Lai, P.B.S

    Published in European journal of surgical oncology (01-09-2007)
    “…Abstract Background Variations of serum AFP levels in HCC patients and cell lines are likely due to the differential activity of enhancer/silencer elements…”
    Get full text
    Journal Article
  4. 4

    Identification of hepatitis B virus X gene mutation in Hong Kong patients with hepatocellular carcinoma by Chen, G.G., Li, M.Y., Ho, R.L.K., Chak, E.C.W., Lau, W.Y., Lai, P.B.S.

    Published in Journal of clinical virology (01-09-2005)
    “…Chronic infection by hepatitis B virus (HBV) is the leading cause of hepatocellular carcinoma (HCC) in man. The viral transactivator HBV X (HBx) gene plays a…”
    Get full text
    Journal Article
  5. 5

    HBx mutants differentially affect the activation of hypoxia-inducible factor-1[alpha] in hepatocellular carcinoma by Liu, L-p, Hu, B-g, Ye, C, Ho, R L K, Chen, G G, Lai, P B S

    Published in British journal of cancer (18-02-2014)
    “…Mutations in HBx gene are frequently found in HBV-associated hepatocellular carcinoma (HCC). Activation of hypoxia-inducible factor-1α (HIF-1α) contributes to…”
    Get full text
    Journal Article
  6. 6

    Systemic cytokine response after laparoscopic-assisted resection of rectosigmoid carcinoma : A prospective randomized trial by KA LAU LEUNG, LAI, P. B. S, HO, R. L. K, MENG, W. C. S, YIU, R. Y. C, LEE, J. F. Y, WAN YEE LAU

    Published in Annals of surgery (01-04-2000)
    “…To compare the systemic cytokine response in patients after laparoscopic-assisted resection with those after open resection of rectosigmoid carcinoma…”
    Get full text
    Journal Article
  7. 7

    PROSPECTIVE RANDOMIZED CONTROL STUDY ON THE EFFECT OF BRANCHED-CHAIN AMINO ACIDS IN PATIENTS WITH LIVER RESECTION FOR HEPATOCELLULAR CARCINOMA by Meng, W. C. S., Leung, K. L., Ho, R. L. K., Leung, T. W. T., Lau, W. Y.

    “…Background: Aminoleban EN contains branched‐chain amino acids (BCAA) and is known to be beneficial for the protein‐energy malnutrition in cirrhotic patients…”
    Get full text
    Journal Article
  8. 8

    Decreased expression of Bid in human hepatocellular carcinoma is related to hepatitis B virus X protein by Chen, G.G., Lai, P.B.S., Chan, P.K.S., Chak, E.C.W., Yip, J.H.Y., Ho, R.L.K., Leung, B.C.S., Lau, W.Y.

    Published in European journal of cancer (1990) (01-09-2001)
    “…As a mitochondrial membrane death ligand, Bid oligomerises Bak to release cytochrome C and its deficiency renders hepatocytes resistant to apoptosis induced by…”
    Get full text
    Journal Article